Detalhe da pesquisa
1.
Proof of concept of triple COMBI therapy to prohibit MPN progression to AML.
Br J Haematol
; 204(1): 16-18, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957927
2.
HSC Niche Dynamics in Regeneration, Pre-malignancy, and Cancer: Insights From Mathematical Modeling.
Stem Cells
; 41(3): 260-270, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36371719
3.
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms.
Eur J Haematol
; 112(5): 776-787, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38226781
4.
Interferon alpha-2 treatment reduces circulating neutrophil extracellular trap levels in myeloproliferative neoplasms.
Br J Haematol
; 202(2): 318-327, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37211985
5.
Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia-chromosome negative myeloproliferative neoplasms.
Eur J Haematol
; 111(5): 805-814, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640394
6.
High JAK2V617F variant allele frequency is associated with coronary artery but not aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms.
Eur J Haematol
; 111(3): 400-406, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37286366
7.
Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-up.
Eur J Haematol
; 109(5): 576-585, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054308
8.
Smoking impairs molecular response, and reduces overall survival in patients with chronic myeloproliferative neoplasms: A retrospective cohort study.
Br J Haematol
; 193(1): 83-92, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33169852
9.
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population.
Blood
; 134(5): 469-479, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31217187
10.
Data-driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Eur J Haematol
; 107(6): 624-633, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34411333
11.
Smoking, blood cells and myeloproliferative neoplasms: meta-analysis and Mendelian randomization of 2·3 million people.
Br J Haematol
; 189(2): 323-334, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31875952
12.
Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer.
Cancer Immunol Immunother
; 69(2): 315-324, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31915854
13.
Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer's disease: evidences and perspectives.
J Neuroinflammation
; 17(1): 248, 2020 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32829706
14.
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study.
Haematologica
; 105(9): 2262-2272, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054051
15.
The red blood cell count and the erythrocyte sedimentation rate in the diagnosis of polycythaemia vera.
Eur J Haematol
; 104(1): 46-54, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31584701
16.
International external quality assurance of JAK2 V617F quantification.
Ann Hematol
; 98(5): 1111-1118, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30535576
17.
Bridging blood cancers and inflammation: The reduced Cancitis model.
J Theor Biol
; 465: 90-108, 2019 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30615883
18.
Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.
Eur J Haematol
; 103(1): 26-34, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30985947
19.
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatment.
Eur J Haematol
; 103(4): 351-361, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31297883
20.
Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia.
Platelets
; 30(2): 206-212, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-29215956